Apontis Pharma AG (ETR:APPH)
Germany
· Delayed Price · Currency is EUR 11.45
+0.30 (2.69%)
Apr 24, 2025, 5:36 PM CET
Apontis Pharma AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Revenue | 48.47 | 36.96 | 55.73 | 51.18 | 39.24 | Upgrade
|
| Revenue Growth (YoY) | 31.12% | -33.67% | 8.88% | 30.44% | -1.99% | Upgrade
|
| Cost of Revenue | 20.77 | 13.79 | 20.74 | 17.4 | 14.22 | Upgrade
|
| Gross Profit | 27.7 | 23.17 | 34.99 | 33.79 | 25.03 | Upgrade
|
| Selling, General & Admin | 14.99 | 20.97 | 20.19 | 19.73 | 18.13 | Upgrade
|
| Other Operating Expenses | 9.29 | 9.97 | 9.24 | 8.23 | 5.96 | Upgrade
|
| Operating Expenses | 26.51 | 32.81 | 31.22 | 29.49 | 25.74 | Upgrade
|
| Operating Income | 1.19 | -9.64 | 3.77 | 4.3 | -0.72 | Upgrade
|
| Interest Expense | -0.12 | -0.02 | - | -0.35 | -0.81 | Upgrade
|
| Interest & Investment Income | 0.06 | 0.34 | 0.06 | 0 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | 0 | -0.05 | 0 | - | Upgrade
|
| EBT Excluding Unusual Items | 1.14 | -9.32 | 3.79 | 3.95 | -1.52 | Upgrade
|
| Merger & Restructuring Charges | - | -5.57 | - | - | - | Upgrade
|
| Asset Writedown | -0.01 | -0.01 | - | -0.22 | - | Upgrade
|
| Other Unusual Items | - | - | - | -3.52 | - | Upgrade
|
| Pretax Income | 1.13 | -14.89 | 3.79 | 0.21 | -1.52 | Upgrade
|
| Income Tax Expense | 0.37 | -3.59 | 1.1 | 0.96 | -0.34 | Upgrade
|
| Net Income | 0.75 | -11.3 | 2.69 | -0.75 | -1.18 | Upgrade
|
| Net Income to Common | 0.75 | -11.3 | 2.69 | -0.75 | -1.18 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 8 | 8 | 9 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 8 | 8 | 9 | 7 | Upgrade
|
| Shares Change (YoY) | - | - | -2.00% | 30.77% | - | Upgrade
|
| EPS (Basic) | 0.09 | -1.36 | 0.32 | -0.09 | -0.18 | Upgrade
|
| EPS (Diluted) | 0.09 | -1.36 | 0.32 | -0.09 | -0.18 | Upgrade
|
| Free Cash Flow | -2.92 | -12.6 | 10.94 | 3.43 | 1.45 | Upgrade
|
| Free Cash Flow Per Share | -0.35 | -1.51 | 1.31 | 0.40 | 0.22 | Upgrade
|
| Gross Margin | 57.16% | 62.68% | 62.79% | 66.01% | 63.77% | Upgrade
|
| Operating Margin | 2.46% | -26.09% | 6.77% | 8.40% | -1.83% | Upgrade
|
| Profit Margin | 1.55% | -30.58% | 4.83% | -1.46% | -3.02% | Upgrade
|
| Free Cash Flow Margin | -6.02% | -34.09% | 19.62% | 6.70% | 3.69% | Upgrade
|
| EBITDA | 3.43 | -7.76 | 5.52 | 5.82 | 0.81 | Upgrade
|
| EBITDA Margin | 7.08% | -21.01% | 9.91% | 11.38% | 2.07% | Upgrade
|
| D&A For EBITDA | 2.24 | 1.88 | 1.75 | 1.52 | 1.53 | Upgrade
|
| EBIT | 1.19 | -9.64 | 3.77 | 4.3 | -0.72 | Upgrade
|
| EBIT Margin | 2.46% | -26.09% | 6.77% | 8.40% | -1.83% | Upgrade
|
| Effective Tax Rate | 33.04% | - | 29.04% | 447.01% | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.